Dual-response CuS@MnO2 nanoparticles with activatable CT/MR-enhanced in vivo imaging guided photothermal therapy-Reference-Cited by-同舟云学术

Dual-response CuS@MnO2 nanoparticles with activatable CT/MR-enhanced in vivo imaging guided photothermal therapy

Published:2019 Issue:5 Volume:9 Page:2718-2730
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Huang Hongbo¹²³⁴⁵^ORCID,Li Ke¹²³⁴⁵,Liu Qingzhu¹²³⁴⁵,Zhao Yunlei⁶⁷⁸⁹¹⁰,Xu Huiting¹¹¹²¹³¹⁰,Wu Wenjuan¹¹¹²¹³¹⁰,Sun Kairong¹¹¹²¹³¹⁰,Ni Jianming¹¹¹²¹³¹⁰,Lin Jianguo¹²³⁴⁵^ORCID

Affiliation:

1. Key Laboratory of Nuclear Medicine

2. Ministry of Health

3. Jiangsu Key Laboratory of Molecular Nuclear Medicine

4. Jiangsu Institute of Nuclear Medicine

5. Wuxi 214063

6. Collaborative Innovation Center of Chemistry for Life Sciences

7. College of Engineering and Applied Sciences

8. Nanjing University

9. Nanjing

10. China

11. Department of Radiology

12. Wuxi Second Hospital Affiliated to Nanjing Medical University

13. Wuxi

Abstract

A stable multifunctional nanoplatform with superior biocompatibility and excellent targeting function was synthesized for MR/CT image guided PTT treatment, for potential application in clinical cancer treatment.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/RA/C8RA08637K

Reference32 articles.

1. Nanocarriers as an emerging platform for cancer therapy

2. Targeting HIF-1 for cancer therapy